T1	Participants 21 46	childhood and adolescence
T2	Participants 142 266	72 children and adolescents (aged 5 to 19 years old, median 16) with Hodgkin's disease, clinical stages IA-IIB (IA, 18; II2A
T3	Participants 957 1009	Patients without evidence of mediastinal involvement
